Epidermal growth factor receptor (EGFR) is transcriptionally induced by the Y-box binding protein-1 (YB-1) and can be inhibited with Iressa in basal-like breast cancer, providing a potential target for therapy
2007 · Breast Cancer Research · 145 citations
https://doi.org/10.1186/bcr1767